Rotstein; David Mark
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rotstein; David Mark.The latest application filed is for "inhibitors of jnk".
- Rotstein; David Mark - Sunnyvale CA US
| Patent | Date |
|---|---|
| Inhibitors of JNK Grant 8,642,601 - Arzeno , et al. February 4, 2 | 2014-02-04 |
| Inhibitors of JNK App 20110301171 - Arzeno; Humberto Bartolome ; et al. | 2011-12-08 |
| Heterocyclic antiviral compounds Grant 7,714,018 - Lee , et al. May 11, 2 | 2010-05-11 |
| Heterocylic antiviral compounds Grant 7,625,891 - Rotstein , et al. December 1, 2 | 2009-12-01 |
| Octahydro-pyrrolo[3,4-c]pyrrole CCR5 receptor antagonists Grant 7,625,905 - Lemoine , et al. December 1, 2 | 2009-12-01 |
| Heterocyclic antiviral compounds App 20090281133 - Rotstein; David Mark ; et al. | 2009-11-12 |
| Heterocyclic antiviral compounds Grant 7,538,122 - Gabriel , et al. May 26, 2 | 2009-05-26 |
| Heterocyclic antiviral compounds App 20090093501 - Gabriel; Stephen Deems ; et al. | 2009-04-09 |
| Heterocyclic antiviral compounds App 20090028818 - Gabriel; Stephen Deems ; et al. | 2009-01-29 |
| Heterocylic antiviral compounds App 20080249087 - Rotstein; David Mark ; et al. | 2008-10-09 |
| Heterocyclic antiviral compounds App 20080139544 - Gabriel; Stephen Deems ; et al. | 2008-06-12 |
| Heterocylic antiviral compounds App 20080103125 - Lemoine; Remy ; et al. | 2008-05-01 |
| Heterocyclic antiviral compounds Grant 7,332,500 - Gabriel , et al. February 19, 2 | 2008-02-19 |
| Heterocylic antiviral compounds App 20070191335 - Lemoine; Remy ; et al. | 2007-08-16 |
| Heterocyclic antiviral compounds App 20070191406 - Lemoine; Rcmy ; et al. | 2007-08-16 |
| Heterocyclic antiviral compounds App 20070117859 - Lee; Eun Kyung ; et al. | 2007-05-24 |
| Heterocyclic antiviral compounds Grant 7,164,019 - Lee , et al. January 16, 2 | 2007-01-16 |
| Heterocyclic antiviral compounds App 20060014767 - Lee; Eun Kyung ; et al. | 2006-01-19 |
| Pyrazole derivatives-p38 MAP kinase inhibitors Grant 6,979,693 - Goldstein , et al. December 27, 2 | 2005-12-27 |
| Heterocyclic antiviral compounds App 20050176703 - Gabriel, Stephen Deems ; et al. | 2005-08-11 |
| Retinoid compounds (I) Grant 6,777,418 - Lapierre , et al. August 17, 2 | 2004-08-17 |
| Aminopyrrole compounds Grant 6,696,471 - Goldstein , et al. February 24, 2 | 2004-02-24 |
| Aminopyrrole compounds App 20030130319 - Goldstein, David Michael ; et al. | 2003-07-10 |
| Pyrazole derivatives - p38 MAP kinase inhibitors App 20030018051 - Goldstein, David Michael ; et al. | 2003-01-23 |
| Pyrazole derivatives - p38 MAP kinase inhibitors App 20020156114 - Goldstein, David Michael ; et al. | 2002-10-24 |
| Pyrazole derivatives P38 MAP kinase inhibitors Grant 6,444,696 - Goldstein , et al. September 3, 2 | 2002-09-03 |
| Pyrazole derivatives P38 MAP kinase inhibitors App 20020103245 - Goldstein, David Michael ; et al. | 2002-08-01 |
| Retinoid compounds (I) App 20020082265 - Lapierre, Jean-Marc ; et al. | 2002-06-27 |
| Pyrazole derivatives P-38 MAP kinase inhibitors Grant 6,316,466 - Goldstein , et al. November 13, 2 | 2001-11-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 